Neuromodulation, Pain, Survey
Conditions
Brief summary
The goal of this online survey is to gain further insight in the goals, expectations and definition of success for neuromodulation for pain, according to neuromodulation company representatives.
Interventions
Company representatives are questioned about three aspects: 1) goals in treating patients with neuromodulation for pain, 2) factors that respondents expect to change according to neuromodulation for pain and 3) their definition of success of neuromodulation for pain.
Sponsors
Study design
Eligibility
Inclusion criteria
\- Male and female adults who are involved in the management of chronic pain and more specifically in neuromodulation for pain as company representatives will be eligible to complete the survey.
Exclusion criteria
\- Not a company representative.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Company representatives definition of success of neuromodulation for pain, evaluated with a self-constructed question. | Cross-sectional evaluation during 2nd Joint Congress of the INS European Chapters (e-INS 2021) in Paris in September. | Company representatives their definition of success of neuromodulation for pain. |
| Goals of company representatives, evaluated with a self-constructed question. | Cross-sectional evaluation during 2nd Joint Congress of the INS European Chapters (e-INS 2021) in Paris in September. | Goals of company representatives to treat patients with neuromodulation for pain. |
| Company representatives expectations, evaluated with a self-constructed question. | Cross-sectional evaluation during 2nd Joint Congress of the INS European Chapters (e-INS 2021) in Paris in September. | Factors that respondents expect to change according to neuromodulation for pain. |
Countries
Belgium